PCG
Prosperity Consulting Group’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.26M | Buy |
29,404
+4,107
| +16% | +$455K | 0.24% | 98 |
|
|
2025
Q1 | $2.83M | Sell |
25,297
-1,500
| -6% | -$168K | 0.22% | 105 |
|
|
2024
Q4 | $2.48M | Sell |
26,797
-1,767
| -6% | -$163K | 0.19% | 124 |
|
|
2024
Q3 | $2.39M | Sell |
28,564
-7,806
| -21% | -$654K | 0.19% | 127 |
|
|
2024
Q2 | $2.5M | Sell |
36,370
-16,615
| -31% | -$1.14M | 0.34% | 76 |
|
|
2024
Q1 | $3.88M | Buy |
52,985
+48,832
| +1,176% | +$3.58M | 0.49% | 58 |
|
|
2023
Q4 | $336K | Buy |
+4,153
| New | +$336K | 0.11% | 151 |
|